Head-to-head · Value Score
CoreAge Rx vs RNK Health
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, RNK Health a 71. Here's what each one really costs past month one — and where each one bites back.
CoreAge Rx
Grade A+ · Excellent
Est. first month
$99/mo
Save ~72% vs brand self-payRNK Health
Grade C · Watch List
Est. first month
From $197/mo
From $197/mo (semaglutide injection, all-inclusive)
Save ~44% vs brand self-payThe verdict
CoreAge Rx takes it on Value Score, 93 to 71 — an est. $99/mo first month, with no teaser step-up baked in. RNK Health isn't out of it: Someone who wants one all-in monthly price with the doctor visit and supplies included, and who will confirm the dose-by-dose cost and state coverage during the intake.
CoreAge Rx is a featured partner of this site: one flat, all-in monthly price on both molecules, in all 50 states.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | RNK Health |
|---|---|---|
| Value Score | 93 (A+) | 71 (C) |
| Est. first month | $99/mo | From $197/mo (semaglutide injection, all-inclusive) |
| Save vs brand self-pay | ~72% | ~44% |
| Semaglutide | $99/mo | From $197/mo (injection, all-inclusive) |
| Tirzepatide | $149/mo | From $297/mo (injection, all-inclusive) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
Both molecules at one flat, all-in monthly rate — $99 for semaglutide, $149 for tirzepatide — that doesn't step up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
RNK Health
RNK Health sells semaglutide at $197 a month and tirzepatide at $297, each priced as one all-inclusive monthly figure, alongside a wider menu of NAD+, sermorelin and testosterone-support treatments.
What's good
- RNK Health folds the medication, the physician consultation and prescription, syringes and wipes, and shipping into one monthly figure, with "no hidden fees" stated on each product page
- Both molecules are priced in public before any intake: $197 a month for semaglutide and $297 for tirzepatide
- No introductory month and no multi-month prepay on RNK Health's product pages, so the figure shown is the monthly one
- Cancel or pause any time from the account dashboard, by email or by phone; access runs to the end of the cycle already paid for
- Names the clinical networks behind its care, OpenLoop Health and MD Integrations, and publishes a pharmacy address in Utah
The fine print
- RNK Health's homepage prefixes both prices with "From", and no page says whether the rate rises at higher doses
- The states RNK Health serves are not published anywhere on its site
- No pharmacy is named and no 503A or 503B designation is given on RNK Health's product pages
- Once you submit the intake, RNK Health treats the subscription fee as non-refundable except for medical disqualification or a damaged or undelivered order, and a cancellation must land 72 hours before the next bill
- Injection only on both molecules, with no oral route and no FDA-approved brand-name option
- RNK Health publishes no legal company name for the brand on the pages that sell the medication
We earn a commission when you start treatment through some links on this site, at no extra cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to RNK Health.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. "% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on each provider's site. Not medical advice; see our disclosure.